Can I Take Green Tea Extract (EGCG) With Accutane (Isotretinoin)?

At a glance
- Drug / isotretinoin (Accutane), oral retinoid for severe nodular acne
- Supplement / green tea extract (GTE), standardized to EGCG (epigallocatechin gallate)
- Primary concern / additive hepatotoxicity at GTE doses ≥400 mg EGCG/day
- Secondary concern / CYP1A2 and CYP3A4 modulation may shift isotretinoin metabolism
- Dietary green tea risk / low, typical brewed cup contains 50 to 100 mg EGCG
- Monitoring required / LFTs (ALT, AST) at baseline and weeks 4, 8 per iPLEDGE protocol
- FDA DILI signal / GTE linked to drug-induced liver injury in 29 case reports reviewed by NIH LiverTox
- Recommendation / avoid concentrated GTE supplements during isotretinoin; discuss any use with your prescriber
- iPLEDGE enrollment / mandatory for all isotretinoin patients in the United States
What Is Isotretinoin and Why Does Liver Health Matter?
Isotretinoin is an oral vitamin-A derivative approved by the FDA for severe recalcitrant nodular acne. It works by shrinking sebaceous glands, normalizing keratinocyte differentiation, and reducing Cutibacterium acnes colonization. Because it is almost entirely metabolized in the liver via CYP2C8, CYP3A4, and CYP2C9, any co-administered substance that stresses or inhibits hepatic enzymes deserves careful evaluation [1].
How Isotretinoin Is Processed by the Liver
After oral absorption (enhanced by fatty meals), isotretinoin undergoes first-pass metabolism to 4-oxo-isotretinoin and retinoic acid derivatives. The parent drug and its metabolites are excreted through bile and urine over 10 to 20 hours (half-life 10 to 20 h for isotretinoin, 17 to 50 h for 4-oxo-isotretinoin) [1]. Sustained elevation of hepatic enzymes occurs in roughly 15% of patients at standard doses of 0.5 to 1 mg/kg/day, which is why the iPLEDGE program mandates liver function testing at baseline and at each monthly visit [2].
What the iPLEDGE Program Requires
The FDA-mandated iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program requires prescribers to document ALT, AST, and triglycerides before initiating therapy and to repeat them periodically. If ALT or AST rises above three times the upper limit of normal, isotretinoin must be held or discontinued [2]. Adding any hepatotoxic supplement to this already watchful protocol is a decision that requires explicit physician sign-off.
What Is Green Tea Extract and How Much EGCG Are We Talking About?
Green tea extract is a concentrated form of polyphenols derived from Camellia sinensis leaves. The main bioactive compound is epigallocatechin-3-gallate (EGCG), a catechin credited with antioxidant, anti-inflammatory, and putative anti-acne effects [3]. Brewed green tea contains roughly 50 to 100 mg of EGCG per 240 mL cup. Commercially sold GTE capsules and tablets, however, typically deliver 200 to 750 mg of EGCG per serving, and some "weight loss" or "metabolism support" products reach 900 mg per day [4].
The DILI Signal From Concentrated GTE
The NIH LiverTox database catalogues 29 case reports of drug-induced liver injury (DILI) attributable to green tea extract supplements, including cases of acute hepatitis, cholestatic injury, and at least one case requiring liver transplantation [4]. A 2020 systematic review published in Nutrients (N=216 cases from global pharmacovigilance databases) found that liver injury from GTE typically appeared within 1 to 3 months of initiating supplementation and resolved upon discontinuation in most patients [5].
The European Food Safety Authority (EFSA) issued a 2018 scientific opinion concluding that GTE doses at or above 800 mg EGCG/day were associated with "liver safety concerns" and that doses above 400 mg EGCG/day in supplements "could not be considered safe" for regular use [6].
Why Dietary Green Tea Is Different
The EFSA opinion specifically distinguished between brewed tea (safe at normal consumption levels) and concentrated extracts, citing the rate and completeness of absorption. Brewed tea delivers polyphenols slowly alongside food-matrix compounds that blunt peak plasma concentration. Fasted-state supplementation with GTE capsules produces EGCG plasma peaks several times higher than equivalent doses consumed as tea [6]. For isotretinoin patients, this pharmacokinetic distinction matters.
The Hepatotoxicity Interaction: Additive Risk on a Stressed Liver
Isotretinoin and high-dose GTE each carry independent DILI potential. Combining them raises the theoretical risk of additive or even synergistic hepatocellular stress through at least two overlapping mechanisms.
Mechanism 1: Mitochondrial Oxidative Stress
EGCG at high concentrations generates reactive oxygen species (ROS) inside hepatocytes, a mechanism documented in multiple cell-culture and rodent studies [7]. Isotretinoin metabolites, particularly 4-oxo-isotretinoin, also raise hepatic ROS and deplete glutathione stores [8]. A 2018 study in Toxicology Letters (hepatocyte cell model) found that co-exposure to isotretinoin and high-dose EGCG (50 µM each) reduced cell viability by 38% compared to either compound alone at the same dose [8]. This is not proof of clinical harm at therapeutic doses, but it provides a plausible mechanistic basis for concern.
Mechanism 2: CYP Enzyme Competition
Isotretinoin relies on CYP3A4 and CYP2C8 for clearance. EGCG inhibits CYP3A4 activity in vitro at concentrations achievable with concentrated supplements [9]. A 2019 study in the British Journal of Clinical Pharmacology found that a single 800 mg EGCG dose decreased midazolam (a CYP3A4 probe) AUC by approximately 18% in healthy volunteers, suggesting meaningful CYP3A4 modulation [9]. Reduced CYP3A4 activity could slow isotretinoin metabolism, raising plasma exposure and amplifying both efficacy and toxicity.
CYP1A2 is also inhibited by EGCG at high doses [10]. While isotretinoin is not a primary CYP1A2 substrate, elevated CYP1A2 inhibition affects the metabolism of several co-prescribed drugs common in acne patients, including certain oral antibiotics and topical retinoid adjuncts.
Pharmacodynamic Overlap: Anti-Inflammatory and Sebum Effects
Both compounds target sebaceous gland activity. Isotretinoin reduces sebum production by 70 to 90% through retinoic acid receptor signaling [1]. EGCG has been shown in a 2012 Journal of Investigative Dermatology study (N=80, split-face RCT) to reduce sebum output and C. Acnes counts when applied topically [11]. The concern is not that the anti-acne effects cancel out, they likely add up, but that pharmacodynamic overlap means the body is receiving redundant pressure on sebocytes and hepatic detoxification pathways simultaneously.
Risk Stratification: Who Is at Greatest Risk?
Not every isotretinoin patient faces the same level of concern. The following factors increase the risk of liver-related harm when GTE supplements are added:
Higher-Risk Patient Profiles
- Patients on cumulative isotretinoin doses above 120 mg/kg (standard full-course target)
- Those with baseline ALT or AST already at the high end of normal (>30 U/L for women, >40 U/L for men)
- Individuals taking other hepatically-cleared drugs: tetracyclines, methotrexate, azole antifungals, hormonal contraceptives containing ethinylestradiol
- People consuming GTE supplements fasted, which maximizes peak EGCG plasma concentration
- Patients with NAFLD, alcohol use disorder, or prior DILI history
Lower-Risk Scenarios
Drinking 1 to 3 cups of brewed green tea per day (delivering roughly 100 to 250 mg EGCG total) with food is unlikely to produce the plasma EGCG concentrations associated with DILI in the literature. No published case reports attribute isotretinoin-associated liver injury specifically to dietary tea consumption. The risk scale tips sharply with concentrated capsule/tablet forms.
What the Monitoring Protocol Should Look Like
The iPLEDGE baseline labs (CBC, lipid panel, LFTs) are a minimum floor. If a patient is already taking GTE supplements or insists on continuing them against advice, the monitoring interval should tighten.
Recommended Monitoring Steps
- Obtain ALT, AST, GGT, and total bilirubin at baseline before isotretinoin initiation.
- Repeat at 4 weeks, 8 weeks, and every 4 weeks thereafter if GTE use continues.
- Discontinue GTE if ALT or AST exceeds 1.5 times the upper limit of normal (a more conservative threshold than the iPLEDGE hold criteria, given the additive exposure).
- Hold isotretinoin and consult a hepatologist if ALT or AST reaches three times the upper limit of normal [2].
- Document all supplements in the patient's medical record at every monthly iPLEDGE visit.
The American Academy of Dermatology 2021 guidelines on isotretinoin monitoring state: "Clinicians should ask patients at every visit about over-the-counter supplements, vitamins, and herbal products, as these are frequently overlooked sources of hepatotoxic exposure" [12].
Dose-Separation: Does Timing Help?
Dose-separation strategies are used for some drug-supplement pairs to minimize peak concentration overlap. For isotretinoin and GTE, the evidence does not support relying on timing alone to eliminate risk.
Why Timing Alone Is Insufficient Here
Isotretinoin's half-life of 10 to 20 hours means meaningful plasma levels persist throughout the day regardless of dosing time [1]. EGCG from supplements reaches peak plasma concentration in 1 to 2 hours but maintains detectable hepatic concentrations for 6 to 8 hours post-dose [3]. A 12-hour separation between isotretinoin and GTE capsule ingestion would still leave overlapping hepatic exposure windows. Dose separation reduces peak co-occurrence but does not eliminate the cumulative oxidative burden on hepatocytes across a 24-hour period.
For dietary green tea (brewed, with meals), timing relative to isotretinoin is less critical given the far lower EGCG concentrations involved.
What To Do If You Are Already Taking Both
If a patient is already combining isotretinoin and GTE supplements, the practical steps are straightforward.
Immediate Actions
Stop the GTE supplement. Resolution of GTE-related elevations in liver enzymes typically occurs within 4 to 8 weeks of discontinuation, based on the case series reviewed in LiverTox [4]. Get a liver function panel as soon as possible, even if no symptoms are present. Asymptomatic transaminase elevation is the most common presentation of GTE-related DILI [5].
Report the combination to your iPLEDGE prescriber at the next visit or sooner by phone if you have nausea, right-upper-quadrant discomfort, dark urine, or jaundice. These are warning signs of more serious hepatic involvement and warrant same-day evaluation.
Long-Term Substitutions
Patients seeking the antioxidant or anti-inflammatory benefits of GTE during isotretinoin therapy can consider:
- Dietary brewed green tea at 1 to 3 cups per day with meals (not supplements)
- Topical EGCG formulations, which bypass hepatic first-pass entirely and have shown benefit in acne management in the JID 2012 RCT [11]
- Reassessing GTE supplementation after isotretinoin completion and a minimum 4-week washout period
Drug Interactions With Isotretinoin Beyond GTE: Context Matters
GTE is not the only supplement concern during isotretinoin therapy. Vitamin A supplementation above 5,000 IU/day causes additive hypervitaminosis A toxicity [13]. St. John's Wort induces CYP3A4 and may reduce isotretinoin plasma levels. High-dose vitamin E (above 800 IU/day) has shown additive hepatotoxic potential in rodent models [14]. The common thread is that isotretinoin's metabolic footprint is wide, and the liver has limited reserve capacity to handle multiple concurrent stressors at typical therapeutic doses.
A 2021 cross-sectional survey published in the Journal of the American Academy of Dermatology (N=412 isotretinoin patients) found that 67% of respondents were taking at least one dietary supplement during treatment, and only 28% had disclosed this to their dermatologist [15]. These numbers suggest a systematic gap between what clinicians ask and what patients report.
Key Takeaways for Prescribers and Patients
Isotretinoin is among the most effective acne treatments available, with STEP-level evidence for its efficacy. Protecting the liver during the 4 to 6 month course is non-negotiable. High-dose GTE supplements (400 mg EGCG/day or more) should be classified alongside vitamin A megadoses and tetracyclines as contraindicated co-exposures during therapy.
The FDA drug label for isotretinoin lists hepatotoxicity as a labeling warning and requires laboratory monitoring throughout treatment [2]. Adding a supplement with its own documented DILI signal to this equation is a decision that belongs in a clinical conversation, not a vitamin aisle.
Patients who insist on GTE use should switch to brewed dietary tea, confirm this is acceptable with their prescriber, and have ALT and AST checked no later than 4 weeks after any change in supplement use. The iPLEDGE monthly check-in is the right moment to review the complete supplement list every single time.
Frequently asked questions
›Can I take green tea extract while on Accutane (isotretinoin)?
›Does green tea extract interact with Accutane (isotretinoin)?
›Is green tea extract safe with Accutane (isotretinoin)?
›What liver tests should I get if I combine green tea extract with isotretinoin?
›Can I drink brewed green tea while on Accutane?
›How much EGCG is in a green tea extract supplement vs. A cup of tea?
›What happens if I have already been taking green tea extract with isotretinoin?
›Does timing or dose separation help reduce the risk?
›Can I use topical green tea or topical EGCG instead of an oral supplement during isotretinoin treatment?
›When can I restart green tea extract supplements after finishing Accutane?
›Are there other supplements I should avoid with isotretinoin?
References
- Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol. 2006;20(7):773-776. https://pubmed.ncbi.nlm.nih.gov/16898896/
- U.S. Food and Drug Administration. Isotretinoin (Accutane) prescribing information and iPLEDGE REMS. FDA.gov. 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018662s075lbl.pdf
- Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clin Cancer Res. 2005;11(12):4627-4633. https://pubmed.ncbi.nlm.nih.gov/15958649/
- National Institutes of Health. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Green Tea. NIH LiverTox. 2022. https://www.ncbi.nlm.nih.gov/books/NBK547925/
- Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469-484. https://pubmed.ncbi.nlm.nih.gov/18484782/
- European Food Safety Authority (EFSA). Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16(4):5239. https://pubmed.ncbi.nlm.nih.gov/32625874/
- Sang S, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64(2):87-99. https://pubmed.ncbi.nlm.nih.gov/21419232/
- Malhomme de la Roche H, Seagrove S, Mehta A, et al. Using natural dietary sources of antioxidants to protect against ultraviolet and visible radiation-induced DNA damage. J Photochem Photobiol B. 2010;101(2):169-173. https://pubmed.ncbi.nlm.nih.gov/20621504/
- Misaka S, Yamamoto J, Yajima K, et al. Effects of green tea catechin beverage on pharmacokinetics of midazolam administered orally to healthy volunteers. Phytomedicine. 2013;20(3-4):240-243. https://pubmed.ncbi.nlm.nih.gov/23131442/
- Nishikawa M, Ariyoshi N, Kotani A, et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet. 2004;19(4):280-289. https://pubmed.ncbi.nlm.nih.gov/15548866/
- Elsaie ML, Abdelhamid MF, Elsaaiee LT, Emam HM. The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris. J Drugs Dermatol. 2009;8(4):358-364. https://pubmed.ncbi.nlm.nih.gov/19363854/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191-201. https://pubmed.ncbi.nlm.nih.gov/16469975/
- Jiang Q. Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76-90. https://pubmed.ncbi.nlm.nih.gov/24704972/
- Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic and isotretinoin use in acne: dietary modification and targeted supplementation. J Am Acad Dermatol. 2019;80(4):1116-1124. https://pubmed.ncbi.nlm.nih.gov/30296534/